SCHEMBL206453

SCHEMBL206453

CCCCCCCc1ccc(Nc2nc(Cc3ccccc3)cs2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 2/20 0.59
ADRB2 P07550 1/20 0.59
ADRB1 P08588 1/20 0.59
PDE5A O76074 1/20 0.46
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
PDE1C Q14123 1/20 0.46
SPHK1 Q9NYA1 1/20 0.44
GAA P10253 4/20 0.43
RAB9A P51151 3/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 1/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206449 0.88 TDP1 (0.50) ADRB3ADRB2ADRB1SPHK1GAA
SCHEMBL206347 0.87 ADRB2 (0.48) ADRB3ADRB2ADRB1SPHK1GAA
SCHEMBL2697797 0.85 ADRB2 (0.51) ADRB3ADRB2ADRB1GAARAB9A
SCHEMBL5494002 0.83 ADRB2 (0.74) ADRB3ADRB2ADRB1SPHK1GAA
SCHEMBL2706607 0.83 ADRB2 (0.49) ADRB3ADRB2ADRB1GAARAB9A
SCHEMBL491436 0.82 ADRB2 (0.72) ADRB3ADRB2ADRB1SPHK1GAA
SCHEMBL205278 0.80 ADRB2 (0.46) ADRB3ADRB2ADRB1GAARAB9A
SCHEMBL27812589 0.78 ADRB2 (0.67) ADRB3ADRB2ADRB1SPHK1GAA
SCHEMBL207085 0.77 PTGS2 (0.47) ADRB3ADRB2ADRB1GAARAB9A
SCHEMBL12050132 0.77 ALDH1A1 (0.65) ADRB3ADRB2ADRB1SPHK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ADRB3 610/4885ADRB2 1337/4885ADRB1 185/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ADRB3 610/4885ADRB2 1337/4885ADRB1 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.